1. Home
  2. SPE vs MDXH Comparison

SPE vs MDXH Comparison

Compare SPE & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Special Opportunities Fund Inc

SPE

Special Opportunities Fund Inc

HOLD

Current Price

$14.08

Market Cap

158.8M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.37

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPE
MDXH
Founded
1993
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
158.8M
183.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SPE
MDXH
Price
$14.08
$3.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
44.8K
97.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
8.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.31
Revenue Next Year
N/A
$18.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$1.36
52 Week High
$15.99
$5.33

Technical Indicators

Market Signals
Indicator
SPE
MDXH
Relative Strength Index (RSI) 26.68 46.21
Support Level $13.95 $3.05
Resistance Level $15.59 $3.78
Average True Range (ATR) 0.18 0.16
MACD -0.06 -0.00
Stochastic Oscillator 10.40 26.36

Price Performance

Historical Comparison
SPE
MDXH

About SPE Special Opportunities Fund Inc

Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: